Inrebic
| Inrebic | |
|---|---|
| Term | Inrebic |
| Short definition | Inrebic (in-REH-bik) A drug used to treat adults with moderate- and high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF. It is also being studied in the treatment of other conditions. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Inrebic - (pronounced) (in-REH-bik) A drug used to treat adults with moderate- and high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF. It is also being studied in the treatment of other conditions. Inrebic blocks JAK2 and other proteins that can help prevent abnormal blood cells or cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called fedratinib hydrochloride
External links
- Medical encyclopedia article on Inrebic
- Wikipedia's article - Inrebic
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski